Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima–media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lowering Italian Study
暂无分享,去创建一个
S Collatina | G Mancia | G. Mancia | G. Gallus | A. Zanchetti | M. Bond | F. Veglia | G. Crepaldi | A. Ventura | G. Baggio | A Zanchetti | F Veglia | G Crepaldi | L Sampieri | P Rubba | M G Bond | P. Rubba | S. Collatina | L. Sampieri | G V Gallus | A Ventura | G Baggio | E Serrotti | E. Serrotti
[1] O. Joakimsen,et al. Sex differences in the relationship of risk factors to subclinical carotid atherosclerosis measured 15 years later : the Tromsø study. , 2000, Stroke.
[2] D. Grobbee,et al. Carotid artery intima‐media thickness as an indicator of generalized atherosclerosis , 1994, Journal of internal medicine.
[3] W M O'Fallon,et al. Duration of cigarette smoking is the strongest predictor of severe extracranial carotid artery atherosclerosis. , 1990, Stroke.
[4] L. Chambless,et al. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. , 1991, American journal of epidemiology.
[5] M. Bond,et al. Carotid plaque associations among hypertensive patients. , 1993, Archives of internal medicine.
[6] M. Mercuri,et al. Quantitative Ultrasonographic Evaluation of the Carotid Arteries in Hypertension , 1995, Journal of cardiovascular risk.
[7] R. Dempsey,et al. Amount of Smoking Independently Predicts Carotid Artery Atherosclerosis Severity , 1992, Stroke.
[8] A. Zanchetti. The hypertensive patient with multiple risk factors: is treatment really so difficult? , 1997, American journal of hypertension.
[9] R. Kronmal,et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.
[10] A. Nicolaides,et al. Measurement of the ultrasonic intima-media complex thickness in normal subjects. , 1993, Journal of vascular surgery.
[11] A. Visoná,et al. Noninvasive study of arterial hypertension and carotid atherosclerosis. , 1990, Stroke.
[12] A. Rantala,et al. Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis , 1996, Journal of hypertension.
[13] A. Hofman,et al. Hormone replacement therapy and intima-media thickness of the common carotid artery: the Rotterdam study. , 1999, Stroke.
[14] Richard A. Kronmal,et al. Distribution and Correlates of Sonographically Detected Carotid Artery Disease in the Cardiovascular Health Study , 1992, Stroke.
[15] Bruce Neal,et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. , 1999, Journal of hypertension.
[16] J. Salonen,et al. Carotid atherosclerosis in relation to systolic and diastolic blood pressure: Kuopio Ischaemic Heart Disease Risk Factor Study. , 1991, Annals of medicine.
[17] L. Kuller,et al. Morbidity, mortality, and antihypertensive treatment effects by extent of atherosclerosis in older adults with isolated systolic hypertension. , 1995, Stroke.
[18] S. Azen,et al. Reduction in Carotid Arterial Wall Thickness Using Lovastatin and Dietary Therapy , 1996, Annals of Internal Medicine.
[19] G Parati,et al. Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment. , 1989, The American journal of medicine.
[20] A. Zanchetti. Carotid artery wall alterations as intermediate end points. , 1999, Clinical and experimental hypertension.
[21] P Pignoli,et al. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. , 1988, Atherosclerosis.
[22] A. Zanchetti. Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA) , 1995, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[23] P M Rautaharju,et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. , 1995, Stroke.
[24] M. Bond,et al. Detection and monitoring of asymptomatic atherosclerosis in clinical trials. , 1989, The American journal of medicine.
[25] J. Ruidavets,et al. Carotid intima-media thickness and coronary heart disease risk factors in a low-risk population. , 1999 .
[26] A. Zanchetti,et al. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): Results of long‐term randomized treatment with either verapamil or chlorthalidone on carotid intima‐media thickness , 1998, Journal of hypertension.
[27] A. Rantala,et al. Prevalence of carotid atherosclerosis in middle-aged hypertensive and control subjects. A cross-sectional systematic study with duplex ultrasound , 1996, Journal of hypertension.
[28] M A Espeland,et al. Associations of risk factors with segment-specific intimal-medial thickness of the extracranial carotid artery. , 1999, Stroke.
[29] S. Wolfson,et al. Carotid and lower extremity arterial disease in elderly adults with isolated systolic hypertension. , 1987, Stroke.
[30] G. Gallus,et al. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. , 1996, The American journal of medicine.
[31] Stephen B. Manuck,et al. Psychological stress and the progression of carotid artery disease , 1997, Journal of hypertension.
[32] A. Zanchetti. The antiatherogenic effects of antihypertensive drugs: experimental and clinical evidence. , 1992, Clinical and experimental hypertension. Part A, Theory and practice.
[33] M. Rocco,et al. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. , 1996, JAMA.
[34] C. Furberg,et al. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II) , 1995, The American journal of cardiology.
[35] J. Salonen,et al. Risk factors for carotid and femoral atherosclerosis in hypercholesterolaemic men , 1994, Journal of internal medicine.
[36] J. Salonen,et al. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. , 1995, Circulation.
[37] N. Nishi,et al. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. , 1997, Stroke.
[38] M. Trevisan,et al. Multiple risk factors in hypertension: results from the Gubbio Study , 1990, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.